Navigation Links
Hepatitis A Vaccine for Children Lasts for 10 Years: Study
Date:8/14/2012

TUESDAY, Aug. 14 (HealthDay News) -- Children younger than 2 who are given the hepatitis A vaccine are protected from the virus for 10 years, a new study shows.

Hepatitis A is a virus that causes inflammation of the liver, and typically is found in areas with poor sanitation where it is transmitted through contaminated food and water.

Researchers from the U.S. Centers for Disease Control and Prevention found that the transfer of a mother's hepatitis A antibodies -- which help defend against the virus -- to her child does not reduce the effectiveness of the vaccine, which is routinely given to children between 12 months and 18 months old.

In conducting the study, the researchers examined nearly 200 infants and toddlers who were born at full term and healthy at 6 months of age. The children were divided into three groups based on their age: The first group was comprised of babies between 6 months and 12 months old, toddlers between 12 months and 18 months old formed the second group and those from 15 months to 21 months of age made up the third group.

The children's mothers also were tested for hepatitis A antibodies.

The children's hepatitis A antibody levels were measured at 1 month and 6 months. The researchers also conducted follow-up assessments at 3, 5, 7 and 10 years old, after the children received their second dose of the hepatitis A vaccine.

The study found that one month after they received the second dose of the vaccine, children in all three groups showed signs of protection from the virus. At the 10-year follow-up, most of the children were still protected form the virus.

The researchers noted that 7 percent of the 6- to 12-month-old babies born to mothers who did not have hepatitis A antibodies did not retain the protection from the virus provided by the vaccine. Moreover, 11 percent of the children from this group whose mothers did have hepatitis A antibodies also lost their protection.

The researchers also found that 4 percent of the children between 15 months and 21 months old who were born to women without hepatitis A antibodies no longer had protection from the virus after 10 years.

"Our study demonstrates that [the effects of] a hepatitis A [vaccine] persists for at least 10 years after primary vaccination ... when administered to children at ages 12 months and older, regardless of their mothers' anti-hepatitis A status," study author Dr. Umid Sharapov, an epidemiologist with the CDC, said in a news release. "These findings support current CDC ... guidelines for routine administration of two doses of inactivated hepatitis A vaccine to all children in the U.S., beginning at the age of 12 months."

The study authors added that a future booster dose may be necessary for children to maintain protection against hepatitis A.

The study was published in the August issue of the journal Hepatology.

More information

The U.S. National Institutes of Health provides more information on hepatitis A.

-- Mary Elizabeth Dallas

SOURCE: Wiley, news release, Aug. 9, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Hepatitis C Treatment May Hamper Kids Growth
2. Hepatitis A vaccination in children under 2 remains effective for 10 years
3. World Hepatitis Day - EASL calls on the United Nations to join the effort to tackle viral hepatitis
4. Smoking Tied to Risk for Hepatitis Return After Liver Transplant
5. NIH scientists identify likely predictors of hepatitis C severity
6. Herbal remedy used to treat hepatitis C proves ineffective, Penn study finds
7. Adding Vitamin B12 to Standard Drugs Might Help Fight Hepatitis C
8. Hepatitis C may increase deaths from both liver-related and other diseases
9. Milk Thistle of Little Help Against Hepatitis C: Study
10. Helper T cells, not killer T cells, might be responsible for clearing hepatitis A infection
11. Hepatitis C Virus Levels Higher in Certain Injection Drug Users
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hepatitis A Vaccine for Children Lasts for 10 Years: Study
(Date:2/23/2017)... ... February 23, 2017 , ... CALNOC, the nation’s first and ... keynote their upcoming conference – Empowerment, Value and Collaboration – in Seattle, WA on ... of the Virginia Mason Health System in Seattle since 2000. In addition to his ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Thomas Vas-Don ... and disciplined exercise regime, the author was able to successfully recover. In “ Origin ... relevant information for various sources on the principals of massage, anatomy , ...
(Date:2/22/2017)... Boca Raton, FL (PRWEB) , ... February 22, 2017 , ... ... made primarily from deer antler velvet, announced its products are coming soon to Amazon.com, ... by Clint and Shelley Thomson as a means to develop an effective natural treatment ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... certification exam and eligibility requirements effective with the April 2017 testing period. NACCM, ... , “The Care Manager Certified (CMC) exam is periodically re-calibrated to ensure ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, ... or not filling a prescription because they could not afford to pay for ... medications were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... On Wednesday, February 22, 2017, US ... of nine sectors finished the trading sessions in green, four ... Major US indices were also mixed at the close of ... slightly down by 0.09%; the Dow Jones Industrial Average edged ... closed at 2,362.82, down 0.11%. This Thursday morning, Stock-Callers.com looks ...
(Date:2/23/2017)... 2017 ML Capital Group, Inc. (USOTC: MLCG) ... Highlife Tours , a Colorado -based cannabis ... Puration, Inc. (USOTC: PURA) to enter Colorado,s ... Colorado Highlife Tours acquisition announced today is intended to accelerate MLCG,s ... ...
(Date:2/23/2017)... and VANCOUVER, British Columbia , ... OGXI ) today announced its year end 2016 ... In January 2017, OncoGenex, and Achieve Life Science, Inc., ... have entered into a definitive merger agreement under which ... completion of the proposed merger, Achieve,s stockholders are expected ...
Breaking Medicine Technology: